Sürdürülebilir Kalkınma Amaçları

Bu dergideki yayınlar

5 →
  • MakaleAçık Erişim2022Scopus SJRQ4
    Different spacer-arm attached magnetic nanoparticles for covalent immobilization of Jack bean urease

    Gulesci, Nuri; Yucebilgic, Guzide; Yildirim, Deniz

    Objectives: This study aims the covalent immobilization of Jack bean urease on Fe3O4 magnetic nanoparticles via glutaraldehyde (urease@MNPs-Si-Glu) and epichlorohydrin (urease@MNPs-ECH) spacer arms. Methods: The optimum pH and temperature, thermal, storage and reuse stability of free and immobilized urease preparations were investigated. Thermodynamics characterizations of free and immobilized urease preparations were also studied. Results: The free urease and both immobilized urease preparations showed maximal catalytic activity at pH 7.5. The free urease had a maximal catalytic activity at 50 °C, while the both immobilized urease preparations exhibited their maximal catalytic activities at 70 °C. The urease@MNPs-Si-Glu and urease@MNP-ECH showed 2.7- and 1.9-fold higher thermal stability than the free urease at 60 °C, respectively. The free urease remained 30% of their initial activity at 4 °C, while urease@MNPs-Si-Glu and urease@MNPs-ECH retained 72 and 60% of their initial activities at the same conditions. The urease@MNPs-Si-Glu and urease@MNPs-ECH preserved 53 and 52% of their initial activities, respectively for urea hydrolysis after 20 reuses. Conclusions: The urease@MNPs-Si-Glu and urease@MNPsECH may find a potential application area in urea hydrolysis.

    AtıfScopus3WoS2OpenAlex3
    ScopusWeb of ScienceTR Dizinİncele
  • MakaleYalnız künye2015Scopus SJRQ3
    Evaluation of oxidative stress balance in acute deep vein thrombosis

    Doğan, Orhan Veli; Doğan, Süheyla; Coşkun, Ceyhun; Menteşe, Seda Öztaş; Menteşe, Ümit; Mentese, Ahmet; Alver, Ahmet; Turan, İbrahim; Sumer, Aysegul

    Bu çalışmanın amacı akut derin ven trombozlu (DVT) hastalarda toplam oksidan durum (TOS), toplam antioksidan durum (TAS) ve oksidatif stres indeksi (OSI) düzeylerini ölçerek oksidatif stres ve DVT arasındaki ilişkiyi ortaya koymak ve klinisyenlerin bu hastalarda oksidatif stresi dengelemek üzere koruyucu önlemler almasına yardımcı olmaktır.Metod: Bu çalışmada 52 DVT'li ve 45 DVT olmayan bireylerden alınan serum örneklerinde TOS, TAS ve OSI seviyeleri belirlenerek karşılaştırıldı.Bulgular: TOS ve OSI seviyeleri DVT hastalarında kontrol grubu ile karşılaştırıldığında istatistiksel olarak anlamlı yüksek bulunurken (p<0.0001) TAS seviyelerinde fark görülmedi, p=0.118. Hasta grubu idiopatik ve sekonder DVT olarak iki gruba ayrıldı. TOS ve OSI seviyeleri hem idiyopatik DVT hem de sekonder DVT hastalarında kontrol grubu ile karşılaştırıldığında istatistiksel olarak anlamlı yüksek bulundu (p<0.0001). İdiyopatik DVT hastalarında TAS seviyeleri kontrol grubundan anlamlı yüksek iken sekonder DVT hastalarında fark gözlenmedi. Sonuç: Sonuç olarak ROC eğrisine göre elde edilen spesifite ve sensitivite değerleri TOS ve OSI parametrelerinin DVT'nin tanısında kullanılabilecek birer belirteç olabileceğini göstermektedir. Aynı zamanda oksidatif stres belirteçlerinin belirlenmesi hastalarda oksidatif stresin düzeltilmesi için klinisyenlere gerekli önlemleri alabilmeleri için yol gösterici olabilir

    AtıfTR Dizin1
    TR Dizinİncele
  • MakaleAçık Erişim2015Scopus SJRQ3
    Evaluation of oxidative stress balance in acute deep vein thrombosis; [Akut derin ven trombozunda oksidatif stres dengesinin değerlendirilmesi]

    Menteşe, Ümit; Turan, İbrahim; Doğan, Süheyla; Sümer, Ayşegül; Coşkun, Ceyhun; Alver, Ahmet; Doğan, Orhan Veli; Menteşe, Seda Öztaş; Menteşe, Ahmet

    Objective: The purpose of this study was to show the association between oxidative stress and deep venous thrombosis (DVT) by determining total oxidant status (TOS), total antioxidant status (TAS) and oxidative stress index (OSI) values in patients with DVT and to take precautionary measures to balance oxidative status. Methods: TOS, TAS and OSI levels in serum from 52 individuals with DVT and 45 without DVT were compared. Results: TOS and OSI levels were significantly higher in patients with DVT compared with the control group (p<0.0001), but no difference was observed in TAS levels (p=0.118). The patient group was divided into two subgroups, idiopathic and secondary DVT. TOS and OSI levels were significantly higher patients with both idiopathic DVT and secondary DVT compared to the control group (p<0.0001). TAS levels were significantly higher in patients with idiopathic DVT than in the control group, but no difference was observed in the patients with secondary DVT. Conclusion: Specificity and sensitivity values obtained from the receiver operating characteristic (ROC) curve show that TOS and OSI are both markers that can be used in the diagnosis of DVT. Also, determination of oxidative stress markers may guide clinicians to take necessary precautions to balance oxidative stress in the patients.

    AtıfScopus1WoS1
    ScopusWeb of Scienceİncele
  • MakaleAçık Erişim2013Scopus SJRQ4
    Sequence Variant in the LPIN1 gene in Patients with Metabolic Syndrome

    Kural, Birgul Vanizor; Deger, Orhan; Erem, Cihangir; Yücesan, Fulya Balaban; Barlak, Yasam; Turan, Ibrahim; Aliyazicioglu, Rezzan

    Objective: Metabolic syndrome (MetS) is a complex disease characterized by insulin resistance, abdominal obesity, hyperglycemia, hypertension, hypertriglyceridemia and low HDL-cholesterol level. The aim of the study was to evaluate the sequence variations in the LPIN1 gene in MetS. This gene codes lipin-1 protein which functions as Mg-dependent phosphatidic phosphatase enzyme and transcriptional coactivator. Material and Methods: The study groups included 73 MetS (19 M/54 F) and 56 non-MetS (16 M/40 F). Sequence variation in exons 2, 4, 5 and 14 of the LPIN1 gene were investigated by DNA sequencing method. Results: c.696 G>C variant (p.S232S) in exon 5 was observed in only one women with MetS. But this variation is not important because of coding same amino acid. Conclusion: Any important sequence variant was not detected in exons 2, 4, 5 and 14 in the LPIN1 gene in MetS.

    • SDG 3 · Sağlık ve Kaliteli Yaşam
    AtıfWoS2OpenAlex2TR Dizin1
    Web of ScienceTR Dizinİncele
  • MakaleYayıncıda açık erişim2013Scopus SJRQ4
    Serum anti-carbonic anhydrase I and II antibodies and polycystic ovary syndrome; [Serum anti-karbonik anhidraz I ve II antikorları ve polikistik over sendromu]

    Menteşe, Ahmet; Güven, Süleyman; Sümer, Ayşegül; Turan, Ibrahim; Demir, Selim; Karahan, Süleyman Caner; Alver, Ahmet

    Aim: The aim of this study is to investigate anti-carbonic anhydrase antibodies (anti-CA I and CA II antibodies) in the sera of women with polycystic ovary syndrome (PCOS). Methods: In this study serum anti-CA I and II antibody levels of age and BMI matching fifty women with PCOS and fifty women without PCOS on day three of menstrual cycle were assessed with an ELISA method previously developed by Hosoda and modified by Alver et al. Results: The mean serum anti-CA I antibody levels were significantly higher in women with PCOS and anti-CA II antibody levels were not significantly different in women with PCOS compared with control subjects. For serum anti-CA I antibody, the absorbance higher than 0.484 (mean + 3SD of control subjects) was taken as positive, Anti-CA I antibody was detected in 13 of 50 patients with PCOS (26%). Considering serum anti-CA II antibody, the absorbance higher than 0.654 (mean + 3SD of control subjects) was taken as positive. Anti--CA II antibody was detected in 2 of 50 patients with PCOS (4%). All patients with positive anti-CA II antibody also had positive anti-CA I antibody. Autoantibodies specifically reactive to CA I were found to be present at a higher frequency than CA II in the serum of subjects with PCOS in the present study. Conclusion: The results may suggest that autoimmune responses against CA I may be involved in the pathogenesis of PCOS.

    • SDG 3 · Sağlık ve Kaliteli Yaşam
    AtıfScopus9WoS7OpenAlex8
    ScopusWeb of Scienceİncele
Tam Kayıt
AlanDeğerDil
creativeworkseries.issn0250-4685
dc.date.accessioned2026-10-22T10:20:35.907505666Z
dc.date.available2026-10-22T10:20:35.907505666Z
dc.identifier.urihttps://rdlopen.rawdatalibrary.net/r/gumushane/12835
dc.publisherDe Gruyter Open Ltd
dc.rightsinfo:eu-repo/semantics/openAccess
dc.titleTurkish Journal of Biochemistry